Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeomin vs Sphincterotomy for Chronic Anal Fissure
NCT03855046Phase 4Recruiting
- Sponsor
- State Scientific Centre of Coloproctology
- Start
- Sep 2019
- Primary completion
- Sep 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in chronic anal fissure (CAF), sponsored by State Scientific Centre of Coloproctology. Started Sep 2019; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
chronic anal fissure (CAF)
Beyond the preview
Go deeper on NCT03855046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03855046.